ghk-cu topical use Copper Peptide 0.5% (topical foam) GHK-Cu Topical vs Injection |

Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex

Strategies to reduce the issue: Take with food (for oral formulations) Follow administration with a beverage Consider alternative delivery formats (injection, topical) if taste is bothersome Time doses to minimize coincidence with meals where possible Other Safety Considerations Pregnancy and lactation

Pierwsze efekty widoczne po 48 tygodniach regularnego stosowania

The shelf life of the original lyophilised powder is similarly defined by the manufacturer's data and SmPC

You can tell they all get along and have a great work culture

doi: 10.1016/j.nutos.2022.05.005 133